Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
600mg/12.5mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Teveten HCT is a fixed-dose combination antihypertensive medication containing eprosartan mesylate, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide (HCTZ), a thiazide diuretic. It is indicated for the treatment of hypertension in patients who require combination therapy to achieve adequate blood pressure control. Eprosartan blocks the vasoconstrictive effects of angiotensin II, while hydrochlorothiazide promotes natriuresis and diuresis, resulting in complementary antihypertensive effects. Teveten HCT helps reduce the risk of cardiovascular events associated with uncontrolled high blood pressure.
Fact Table | |
Formula | C23H24N2O4S (eprosartan); C7H8ClN3O4S2 (hydrochlorothiazide) |
License | US FDA (2000); EMA |
Bioavailability | Eprosartan: ~13%; HCTZ: ~60–70% |
Legal status | Prescription only |
Chemical Name | Eprosartan mesylate and hydrochlorothiazide |
Elimination half-life | Eprosartan: ~5–9 hours; HCTZ: ~6–15 hours |
Dosage (Strength) | 600 mg eprosartan / 12.5 mg hydrochlorothiazide tablets |
Pregnancy | Category D – contraindicated in 2nd and 3rd trimester |
Brands | Teveten HCT |
Protein binding | Eprosartan: ~98%; HCTZ: ~40–70% |
PubChem CID | Eprosartan: 3083545; HCTZ: 3639 |
MedlinePlus | a699032 (HCTZ) |
ChEBI | Eprosartan: CHEBI:4808; HCTZ: CHEBI:5778 |
ATC code | C09DA02 |
DrugBank | Eprosartan: DB00876; HCTZ: DB00999 |
KEGG | Eprosartan: D04051; HCTZ: D00340 |
Routes of administration | Oral |
Teveten HCT is administered orally once daily, with or without food.
Renal function, electrolytes, and volume status should be monitored periodically, especially in patients with compromised renal function or those on other diuretics.
Each film-coated tablet contains:
Inactive ingredients may include:
Teveten HCT is contraindicated in patients with:
Use with caution in patients with electrolyte imbalance, hepatic or renal dysfunction, volume depletion, or heart failure. Monitor for hypokalemia, hyponatremia, and hyperuricemia. Thiazide diuretics may exacerbate gout and alter glucose tolerance or lipid levels. Eprosartan may increase serum creatinine or potassium, particularly when used with potassium-sparing agents or supplements. Periodic blood pressure, renal function, and electrolyte monitoring are advised. Avoid use with aliskiren in patients with diabetes or renal impairment (eGFR <60 mL/min/1.73 m²).
Common and potential side effects include: